June 1, 2018

Oncternal Announces Publication of Data from Phase 1 Trial of Cirmtuzumab in CLL in Cell Stem Cell

May 3, 2018

SelectION Appoints Antonius Schuh as New CEO

May 2, 2018

Immusoft Granted Orphan Drug Designation For Treatment Of Rare Childhood Disease

December 12, 2017

Telephus Biosciences Appoints Patrick Vink, M.D., MBA, William Boyle, Ph.D., and Richard Proctor, M.D., as Company Advisors

November 17, 2017

Telephus Medical Founder Awarded $6 Million NIH Grant to Expand Translational Research in Bone Infections

November 16, 2017

Retrotope initiates second patient for Compassionate Use of RT001 for an ultrarare genetic neurological disease, Infantile Neuroaxonal Dystrophy.

October 4, 2017

Zavante Therapeutics Presents Additional Clinical and Microbiologic Data From ZOLYD™ Phase 2/3 Trial at ID Week 2017

September 8, 2017

Zavante Therapeutics Announces Agreement With NIAID To Assess ZOLYD™ For Lower Respiratory Tract Infections

Oncternal Therapeutics: UCSD cancer clinical trial gets $18.2 million

June 6, 2017

Zavante Therapeutics Presents Positive Results From NIH-Sponsored ZOLYD™ Phase 1 Trial At ASM Microbe 2017 Meeting